Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP
Clinical trial NCT00564512 · COMPLETED
Trial details
- NCT number
- NCT00564512
- Sponsor
- French Innovative Leukemia Organisation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2009-01-01
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.